Skip to main content
  • Sign in
Menu
  • Membership
  • Events
  • Knowledge Center
  • About
  • Register
  • Sign In
    • Sign In
    • Register
    • Subscribe
Involvement of ESG/SRI Components in Investing Decisions: United States
2018All-America Research Team
July 1, 2019
verticalcolumnscoverii.png


Related Articles

biotech pharmacy molecule life sciences
Premium

RA Capital Preps New Biotech SPAC — With an Eye on China’s Risks

Stephen Taub
biotech

Biotech Surge Sends Averill to the Top of February’s Market Winners

Stephen Taub
Sunset over an open road with clouds and a partly cloudy sky.

Optimizing the Efficient Frontier: Opportunistic Credit Amid a Capital Structure Reset

Sponsored by Davidson Kempner

Contact Info

New York
1270 Avenue of the Americas, Suite 1100
New York, NY 10020
P: +1 212 224 3300

London
4 Bouverie Street
London EC4Y 8AX
P: +44 207 779 8888

Hong Kong
Unit 2488, 24/F
Lee Garden One,
33 Hysan Avenue
Causeway Bay, Hong Kong
P: +852 2912 8001

Corporate

About Us

Leadership Team

Careers

II Press Room

Digital

Masthead

Thought Leadership

Display Advertising

Reprints

FAQs

Events

Events Calendar

Memberships

Subscription

Subscribe to Premium

Register

Register for Free Account

Newsletters

Sign up for II newsletters

© 2026 Institutional Investor LLC. All material subject to strictly enforced copyright laws. Please read our Terms & Conditions, Modern Slavery Act Transparency Statement, Accessibility Statement and Privacy Policy before using the site.

LinkedIn
X
Bluesky

4.18.00 build:2026-03-26   Login